Company Filing History:
3 out of 1,641 
3 out of 38 
3 out of 132 
Years Active: 1995-2000
Title: John W Jacobs: Innovator in Neoplastic Cell Research
Introduction
John W Jacobs is a notable inventor based in Irvine, California, recognized for his contributions to the field of medical research, particularly in the treatment of neoplastic cells. With a total of four patents to his name, Jacobs has made significant strides in developing methods that aim to combat multidrug-resistant cancer cells.
Latest Patents
One of Jacobs' latest patents is a method for inducing the death of neoplastic cells using piperazine. This innovative approach involves administering a specific compound as a primary chemotherapeutic agent or in conjunction with chemotherapy. The method is designed to effectively induce cell death in patients suffering from multidrug-resistant neoplastic cells. The detailed chemical formulations and mechanisms outlined in the patent highlight the complexity and potential effectiveness of this treatment.
Career Highlights
Throughout his career, John W Jacobs has worked with prominent organizations, including Hitachi Chemical Company, Ltd. and Hitachi Chemical Research Center, Inc. His experience in these companies has contributed to his expertise in the field of chemical research and development.
Collaborations
Jacobs has collaborated with notable colleagues such as Gabriel F Eilon and Gideon A Rodan. These partnerships have likely enriched his research and innovation efforts, leading to advancements in cancer treatment methodologies.
Conclusion
John W Jacobs stands out as a significant figure in the realm of medical innovation, particularly in the fight against cancer. His patents and collaborative efforts reflect a commitment to improving therapeutic strategies for challenging medical conditions.